The present invention relates to a pharmaceutical product packaged in the pharmaceutical formulation comprising a delay of naloxone or a pharmaceutically acceptable salt that - ci and a packaging； a process for the manufacture of a pharmaceutical product is stable on storage, comprising the packaging of a pharmaceutical formulation delay of naloxone or a pharmaceutically acceptable salt that - ci； the use of a packaging for the storage stabilization of a pharmaceutical product comprising a delay in the pharmaceutical formulation of naloxone or a pharmaceutically acceptable salt that - ci； as well as the use of a package in order to reduce the deallylation of naloxone or of its pharmaceutically acceptable salt, for the storage of a pharmaceutical formulation delay of naloxone or a pharmaceutically acceptable salt that - ci.
